OD Flashcards
Features of opioid misuse
rhinorrhoea
needle track marks
pinpoint pupils
drowsiness
watering eyes
yawning
management of opioid overdose
IV or IM naloxone
Management of opioid dependence
refer to CGL if patient complies
specialist drug dependence clinics
NICE recommend methadone or buprenorphine as the first-line treatment in opioid detoxification
compliance is monitored using urinalysis
detoxification should normally last up to 4 weeks in an inpatient/residential setting and up to 12 weeks in the community
benzodiazepines are only prescribed for
short period of time (2-4 weeks).
what may potentiate the signs of benzodiazepine ?
Co-ingestion of alcohol and other central nervous system depressants
benzodiazepine withdrawal syndrome. Features include
insomnia
irritability
anxiety
tremor
Benzodiazepines commonly cause drowsiness,
ataxia,
dysarthria and nystagmus.
Coma, hypotension, bradycardia and respiratory depression
rhabdomyolysis and hypothermia
respiratory depressant effects are more serious in patients with chronic obstructive airways diseas
when should flumanzil not be used ?
At more than the minimum dose required to reverse ventilatory impairment; full reversal of CNS depression is neither necessary, nor desirable
When the risk of convulsions is high, e.g.:
- Known poisoning with a drug that causes convulsions (e.g. a tricyclic antidepressant)
- Features indicate sodium channel blocker or stimulant poisoning (wide QRS interval, tachycardia with large pupils), even if no such agent has been disclosed.
investigations for benzodiazepine ?
FBC, U&Es and LFTs.
Check CK in patients with prolonged loss of consciousness.
ECG abnormalities include transient first degree and second degree block and QT prolongation
arterial/venous blood gas analysis in patients who have a reduced level of consciousness
BNF gives advice on how to withdraw a benzodiazepine
The dose should be withdrawn in steps of about 1/8 (range 1/10 to 1/4) of the daily dose every fortnight.
switch patients to the equivalent dose of diazepam
reduce dose of diazepam every 2-3 weeks in steps of 2 or 2.5 mg
time needed for withdrawal can vary from 4 weeks to a year or more
benzodiazepine OD management ?
Consider activated charcoal if one hour after ingestion
Flumazenil
Flumazenil, a GABA A receptor antagonist, may be used to avoid mechanical ventilation in patients who develop reduced ventilation and coma
due to the risk of seizures with flumazenil. It is generally only used with severe or iatrogenic overdoses.
salicylate overdose leads to a mixed ?
respiratory alkalosis and metabolic acidosis
Features of salicylate OD ?
hyperventilation (centrally stimulates respiration)
tinnitus
lethargy
sweating, pyrexia*
nausea/vomiting
hyperthermia
hyperglycaemia and hypoglycaemia
seizures
salicylate diagnosis ?
bloods :
FBC, U&Es and LFTs. acid-base balance
GLUCOSE
salicylate concentration
ECG
arterial/venous blood gas
Tx of salicylate OD ?
Consider activated charcoal if the patient presents within 1 hour of ingestion
CARDIAC MONITORING
Ensure hypokalaemia is corrected and urinary alkalinisation is instigated prior to intubation where possible
urinary alkalinization with intravenous sodium bicarbonate - enhances elimination of aspirin in the urine
Repeat an urgent salicylate concentration 2 hours after the initial test
consider referral to critical care for patients whose concentrations are around 500 mg/L (3.6 mmol/L) and rising, as they may deteriorate rapidly.
patients who are symptomatic or in patients with rising levels, continue to repeat salicylate concentrations every 2 hours, until concentrations have fallen below 200 mg/L and any clinical features have improved.
haemodialysis indication
serum concentration > 900mg/L
concentrations greater than 700 mg/L (5.1 mmol/L) in patients with a metabolic acidosis
metabolic acidosis resistant to treatment
acute renal failure
pulmonary oedema
seizures
coma
what patients can be considered for observation in salicylate poisoning
Asymptomatic patients with normal acid-base status can be considered for discharge after observation for 6 hours following the overdose, provided their repeat plasma salicylate concentration at least 4 hours after ingestion is below 300 mg/L (2.2 mmol/L) and not rising